BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27059873)

  • 1. N-Acetylcysteine Supplementation in an Individual With Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Psychosis.
    Monsivais SR; Wisdom N; Kruse JL; Davis MC
    Biol Psychiatry; 2016 Oct; 80(8):e71-2. PubMed ID: 27059873
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetylcysteine in trichotillomania: a panacea for compulsive skin disorders?
    Taylor M; Bhagwandas K
    Br J Dermatol; 2014 Nov; 171(5):1253-5. PubMed ID: 24773206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-immunologic characteristics of patients with pulmonary tuberculosis, psychic diseases and a congenital glucose-6-phosphate dehydrogenase deficiency].
    Insanov AB; Aliev NA; Abdullaev FM; Umniashkin AA
    Probl Tuberk; 1989; (6):10-5. PubMed ID: 2771905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical N-acetylcysteine for lamellar ichthyosis.
    Redondo P; Bauzá A
    Lancet; 1999 Nov; 354(9193):1880. PubMed ID: 10584733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine for cholesteatoma?
    Altschuler EL
    J Otolaryngol; 2001 Feb; 30(1):67. PubMed ID: 11770980
    [No Abstract]   [Full Text] [Related]  

  • 6. N-acetylcysteine in trichotillomania: further thoughts.
    Goulding JMR
    Br J Dermatol; 2015 Jun; 172(6):1683-1684. PubMed ID: 25640599
    [No Abstract]   [Full Text] [Related]  

  • 7. N-acetylcysteine in the treatment of skin-picking disorder.
    Silva-Netto R; Jesus G; Nogueira M; Tavares H
    Braz J Psychiatry; 2014; 36(1):101. PubMed ID: 24604468
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal protection by N-acetylcysteine.
    Shehabi Y
    Br J Anaesth; 2007 Feb; 98(2):270; author reply 270-1. PubMed ID: 17251216
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine.
    Cooke NS; McKenna K
    Clin Exp Dermatol; 2007 Jan; 32(1):64-6. PubMed ID: 17305908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals.
    Asevedo E; Cunha GR; Zugman A; Mansur RB; Brietzke E
    Rev Neurosci; 2012; 23(4):353-62. PubMed ID: 22944654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of haemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two cases.
    Vadoud-Seyedi J; de Dobbeleer G; Simonart T
    Br J Dermatol; 2000 Mar; 142(3):580-1. PubMed ID: 10777273
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
    Billinger M; Hess OM; Meier B
    Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417
    [No Abstract]   [Full Text] [Related]  

  • 13. N-acetylcysteine administration in the critically ill.
    Walsh TS; Lee A
    Intensive Care Med; 1999 May; 25(5):432-4. PubMed ID: 10401934
    [No Abstract]   [Full Text] [Related]  

  • 14. N-acetylcysteine: multiple organ saver during cardiac surgery?
    Bouman CC; Schultz MJ
    Crit Care Med; 2008 Jan; 36(1):338-40. PubMed ID: 18158446
    [No Abstract]   [Full Text] [Related]  

  • 15. Is it safe to use N-acetylcysteine in the treatment of bilateral ectropion on collodion baby?
    Pérez-Lopez I; Martinez-López A; Blasco-Morente G; Ruiz-Villaverde R; Tercedor-Sánchez J
    Int J Dermatol; 2017 Apr; 56(4):e71-e72. PubMed ID: 28083950
    [No Abstract]   [Full Text] [Related]  

  • 16. N-Acetylcysteine for Acute Hepatitis Induced by Kratom Herbal Tea.
    Mousa MS; Sephien A; Gutierrez J; OʼLeary C
    Am J Ther; 2018; 25(5):e550-e551. PubMed ID: 28708700
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndrome.
    Izzedine H; Kheder-Elfekih R; Deray G; Thabut D
    J Hepatol; 2009 May; 50(5):1055-6. PubMed ID: 19328583
    [No Abstract]   [Full Text] [Related]  

  • 18. [N-Acetylcysteine--a new possibility in the therapy of hepatic failure].
    Isoniemi H; Pöyhiä R
    Duodecim; 1999; 115(4):361-2. PubMed ID: 11830884
    [No Abstract]   [Full Text] [Related]  

  • 19. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
    Minarini A; Ferrari S; Galletti M; Giambalvo N; Perrone D; Rioli G; Galeazzi GM
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):279-292. PubMed ID: 27766914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of hypes and hopes: N-acetylcysteine and cystatin C.
    Schultz MJ; Royakkers AA; Bouman CS
    AJR Am J Roentgenol; 2008 Mar; 190(3):W224; author reply W225. PubMed ID: 18287418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.